直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Got Demonstrative Exhibits?

August 22, 2014

Authored and Edited by Justin E. Loffredo; Adriana L. Burgy

During oral argument, demonstrative exhibits can be a useful tool to direct the judges to key arguments and points of rebuttal. As specified in the Trial Practice Guide, the Board prohibits the presentation of new evidence in demonstratives. Recent Board orders further detail that prohibition.

For example, the Board in CBS Interactive Inc. v. Helferich Patent Licensing (IPR2013-00033) (Paper 118) (Oct. 23, 2013) proscribed petitioner and patent owner from using any of their demonstrative slides because many, though not all, were non-compliant. The Board’s specific guidance on the appropriate content of demonstrative exhibits included: (1) there is no new evidence or new arguments in demonstratives; (2) there is no proper basis for presenting “written text setting for various statements, characterizations, and assertions” as demonstrative exhibits; and (3) the burden is on the party presenting the demonstrative slide that it does not present new argument or new evidence.

In St. Jude Medical, Cardiology Division, Inc. v. The Board of Regents of the University of Michigan (IPR2013-00041) (Paper 65) (Jan. 27, 2014), the Board explained that demonstratives cannot rely on evidence that was never specifically discussed in any paper before the Board, even if the evidence was in the record. Further, the patent owner’s “demonstrative exhibits constitute a single paper, and thus . . . all of the slides of the demonstratives stand or fall together.” Nevertheless, unlike CBS Interactive, the Board in St. Jude exercised their discretion to allow the use of demonstrative slides, explaining that demonstratives are not evidence, and cautioning that the party’s identification of demonstrative slide numbers during oral argument would not provide a meaningful reference in the official transcript of the hearing.

Other Board orders that are instructive for preparing compliant demonstratives include Corning Gilbert Inc. v. PPC Broadband, Inc. (IPR2013-00340) (Paper 74) (July 23, 2014), where the Board expunged a patent owner’s previously filed demonstratives and allowed a set of conforming demonstratives to be filed by noon on the day before oral argument. In Corning Inc. v. DSM IP Assets B.V. (IPR2013-00043-50, 52, 53) (Paper 92) (February 10, 2014), petitioner objected to patent owner’s demonstratives, arguing that they were voluminous. The Board, however, decided that this was a time management matter to be left to patent owner and allowed use of the demonstratives.

The Trial Practice Guide also provides guidance when lodging an objection to an opponent’s demonstratives. To date, the Board has taken different approaches to objections. For example, in Chicago Mercantile Exchange, Inc. v. 5th Market, Inc. (CBM2013-00027) (Paper 30) (July 27, 2014), the Board required the parties to initiate a conference call at least two business days before the hearing to discuss any issues with either party’s proposed demonstratives. In K-40 Electronics, LLC v. Escort, Inc. (IPR2013-00203, 240) (May 15, 2014), however, the Board required the parties to file written objections to demonstratives at least two business days before the argument. Additionally, the Board required that any objection particularly identify the objected-to demonstrative and explain the reason for the objection.

 

Contacts

Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: March 2026

May 4, 2026

Ad Law Buzz Blog

How to Survive a Section 230 Defense: Recent Cases Provide Guidance

May 1, 2026

Articles

Prosecution History Estoppel: Navigating Limits on Equivalents in Patent Litigation

March/April 2026

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass Patent Litigation Update: November 2025

January 5, 2026

At the PTAB Blog

USPTO Announces Voluntary Search Disclosure Declarations Initiative for PTAB Proceedings

November 19, 2025

Articles

Secondary Considerations in Patent Validity Challenges: Understanding Their Role in IPR and District Court Litigation

November 4, 2025

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: August 2025

October 6, 2025

Articles

Navigating the Future: Ensuring Patentability for AI-Assisted Innovations in the Pharmaceutical and Chemical Space

July/August 2025

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP